These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28887191)

  • 1. Factors influencing participation in colorectal cancer screening programs in Spain.
    Vanaclocha-Espi M; Ibáñez J; Molina-Barceló A; Pérez E; Nolasco A; Font R; Pérez-Riquelme F; de la Vega M; Arana-Arri E; Oceja M; Espinàs JA; Portillo I; Salas D;
    Prev Med; 2017 Dec; 105():190-196. PubMed ID: 28887191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation rates for organized colorectal cancer screening programmes: an international comparison.
    Klabunde C; Blom J; Bulliard JL; Garcia M; Hagoel L; Mai V; Patnick J; Rozjabek H; Senore C; Törnberg S
    J Med Screen; 2015 Sep; 22(3):119-26. PubMed ID: 25967088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
    Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
    J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial participation as a predictor for continuous participation in population-based colorectal cancer screening.
    Saraste D; Öhman DJ; Sventelius M; Elfström KM; Blom J; Törnberg S
    J Med Screen; 2018 Sep; 25(3):126-133. PubMed ID: 28786766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
    Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
    Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing behavioral interventions to optimize participation in a population-based colorectal cancer screening program in Catalonia, Spain.
    Stoffel S; Benito L; Milà N; Travier N; Binefa G; Vidal C; Espinosa J; Moreno V; Garcia M
    Prev Med; 2019 Feb; 119():58-62. PubMed ID: 30594532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.
    Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D
    Trials; 2013 Jul; 14():239. PubMed ID: 23902589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.
    Senore C; Armaroli P; Silvani M; Andreoni B; Bisanti L; Marai L; Castiglione G; Grazzini G; Taddei S; Gasperoni S; Giuliani O; Malfitana G; Marutti A; Genta G; Segnan N
    Am J Gastroenterol; 2010 Jan; 105(1):188-98. PubMed ID: 19826409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation in bowel screening among men attending abdominal aortic aneurysm screening.
    Quyn AJ; Fraser CG; Rodger J; Digan A; Anderson AS; Steele RJC
    Br J Surg; 2018 Apr; 105(5):529-534. PubMed ID: 29465743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.
    Deutekom M; van Rossum LG; van Rijn AF; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
    Scand J Gastroenterol; 2010 Nov; 45(11):1345-9. PubMed ID: 20560814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Main results of the colorectal cancer screening program in the Basque Country (Spain)].
    Portillo I; Idígoras I; Ojembarrena E; Arana-Arri E; Zubero MB; Pijoán JI; López Urrutia A; Marqués ML
    Gac Sanit; 2013; 27(4):358-61. PubMed ID: 23416028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice.
    Multicentre Australian Colorectal-neoplasia Screening (MACS) Group
    Med J Aust; 2006 Jun; 184(11):546-50. PubMed ID: 16768659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
    Hol L; van Leerdam ME; van Ballegooijen M; van Vuuren AJ; van Dekken H; Reijerink JC; van der Togt AC; Habbema JD; Kuipers EJ
    Gut; 2010 Jan; 59(1):62-8. PubMed ID: 19671542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
    Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
    Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.
    Garcia M; Borràs JM; Binefa G; Milà N; Espinàs JA; Moreno V
    Eur J Cancer Prev; 2012 Jan; 21(1):42-5. PubMed ID: 21849903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to and predictors of participation in colorectal cancer screening with faecal occult blood testing in Spain, 2009-2011.
    Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López-de-Andrés A
    Eur J Cancer Prev; 2015 Jul; 24(4):305-12. PubMed ID: 25304027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.